COYA Stock Summary and Trading Ideas (Coya Therapeutics | NASDAQ:COYA)

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Coya Therapeutics trades on the NASDAQ stock market under the symbol COYA.

As of March 31, 2026, COYA stock price climbed to $3.94 with 99,372 million shares trading.

COYA has a beta of 1.22, meaning it tends to be more sensitive to market movements. COYA has a correlation of 0.16 to the broad based SPY ETF.

COYA has a market cap of $92.42 million. This is considered a Micro Cap stock.

Last quarter Coya Therapeutics reported $4 million in Revenue and -$.34 earnings per share. This beat revenue expectation by $844,916 and missed earnings estimates by -$.13.

In the last 3 years, COYA traded as high as $10.69 and as low as $3.21.

The top ETF exchange traded funds that COYA belongs to (by Net Assets): VTI, VXF, IWC, DFAS, DFMC.

COYA has underperformed the market in the last year with a price return of -39.9% while the SPY ETF gained +18.4%. COYA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.9% and -12.4%, respectively, while the SPY returned -5.1% and -2.5%, respectively.

COYA support price is $3.63 and resistance is $3.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COYA shares will trade within this expected range on the day.